9-127612405-T-G

Position:

• chr9-127612405-T-G

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1 PM2 PP5_Moderate

The NM_003165.6(STXBP1):​c.2T>G​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).

• Frequency: Genomes: not found (cov: 30)
• Consequence: STXBP1 NM_003165.6 start_lost
• Clinical Significance: Pathogenic criteria provided, single submitter P:1
• Conservation: PhyloP100: 0.0360

Genes affected

STXBP1 (HGNC:11444): (syntaxin binding protein 1) This gene encodes a syntaxin-binding protein. The encoded protein appears to play a role in release of neurotransmitters via regulation of syntaxin, a transmembrane attachment protein receptor. Mutations in this gene have been associated with infantile epileptic encephalopathy-4. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]

ACMG classification

Verdict is Pathogenic. Variant got 12 ACMG points.

• PVS1: Start lost variant, no new inframe start found.
• PM2: Very rare variant in population databases, with high coverage
• PP5: Variant 9-127612405-T-G is Pathogenic according to our data. Variant chr9-127612405-T-G is described in ClinVar as [Pathogenic]. Clinvar id is 2019337.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
STXBP1	NM_003165.6	c.2T>G	p.Met1?	start_lost	1/20	ENST00000373302.8
STXBP1	NM_001032221.6	c.2T>G	p.Met1?	start_lost	1/19	ENST00000373299.5

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
STXBP1	ENST00000373302.8	c.2T>G	p.Met1?	start_lost	1/20	1	NM_003165.6	P3
STXBP1	ENST00000373299.5	c.2T>G	p.Met1?	start_lost	1/19	1	NM_001032221.6	A1

Frequencies

GnomAD3 genomes Cov.: 30

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 30

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:1

Revision: criteria provided, single submitter

Submissions by phenotype

Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1

Pathogenic, criteria provided, single submitter

clinical testing

Labcorp Genetics (formerly Invitae), Labcorp

Jul 23, 2022

Disruption of the initiator codon has been observed in individual(s) with epileptic encephalopathy (PMID: 34489640). In at least one individual the variant was observed to be de novo. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the STXBP1 mRNA. The next in-frame methionine is located at codon 15. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Pathogenic	0.63	D
BayesDel_noAF	Uncertain	-0.040
CADD	Uncertain	25
DANN	Uncertain	0.98
DEOGEN2	Benign	0.025	.;T;.;T;.
Eigen	Benign	0.12
Eigen_PC	Benign	-0.015
FATHMM_MKL	Benign	0.52	D
LIST_S2	Uncertain	0.90	D;D;D;D;.
M_CAP	Pathogenic	0.99	D
MetaRNN	Pathogenic	0.98	D;D;D;D;D
MetaSVM	Uncertain	-0.12	T
MutationTaster	Benign	0.92	D;D
PROVEAN	Benign	-1.1	N;.;.;N;.
REVEL	Uncertain	0.48
Sift	Uncertain	0.0010	D;.;.;D;.
Sift4G	Uncertain	0.0020	D;.;.;D;.
Polyphen		1.0	D;.;.;D;.
Vest4		0.48
MutPred		0.99		Gain of methylation at M1 (P = 0.0174);Gain of methylation at M1 (P = 0.0174);Gain of methylation at M1 (P = 0.0174);Gain of methylation at M1 (P = 0.0174);Gain of methylation at M1 (P = 0.0174);
MVP		0.84
ClinPred		0.99	D
GERP RS		1.6
Varity_R		0.77
gMVP		0.83

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr9-130374684;